CZ20011785A3 - Pouľití benzoylguanidinů pro oąetřování diabetes mellitus nezávislého na inzulínu - Google Patents

Pouľití benzoylguanidinů pro oąetřování diabetes mellitus nezávislého na inzulínu Download PDF

Info

Publication number
CZ20011785A3
CZ20011785A3 CZ20011785A CZ20011785A CZ20011785A3 CZ 20011785 A3 CZ20011785 A3 CZ 20011785A3 CZ 20011785 A CZ20011785 A CZ 20011785A CZ 20011785 A CZ20011785 A CZ 20011785A CZ 20011785 A3 CZ20011785 A3 CZ 20011785A3
Authority
CZ
Czechia
Prior art keywords
group
methyl
het
insulin
diaminomethylene
Prior art date
Application number
CZ20011785A
Other languages
Czech (cs)
English (en)
Inventor
Rolf Gericke
Manfred Baumgarth
Klaus Minck
Didier Mesangeau
Liliane Doare
Micheline Kergoat
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of CZ20011785A3 publication Critical patent/CZ20011785A3/cs

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4021-aryl substituted, e.g. piretanide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CZ20011785A 1998-11-26 1999-11-16 Pouľití benzoylguanidinů pro oąetřování diabetes mellitus nezávislého na inzulínu CZ20011785A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98122419 1998-11-26

Publications (1)

Publication Number Publication Date
CZ20011785A3 true CZ20011785A3 (cs) 2001-10-17

Family

ID=8233036

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20011785A CZ20011785A3 (cs) 1998-11-26 1999-11-16 Pouľití benzoylguanidinů pro oąetřování diabetes mellitus nezávislého na inzulínu

Country Status (14)

Country Link
EP (1) EP1131064A2 (id)
JP (1) JP2002530325A (id)
KR (1) KR20010080597A (id)
CN (1) CN1328452A (id)
AR (1) AR023064A1 (id)
AU (1) AU1553500A (id)
BR (1) BR9915667A (id)
CA (1) CA2352154A1 (id)
CZ (1) CZ20011785A3 (id)
HU (1) HUP0104418A2 (id)
ID (1) ID29523A (id)
NO (1) NO20012563D0 (id)
PL (1) PL348152A1 (id)
WO (1) WO2000030624A2 (id)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA008769B1 (ru) * 2002-06-05 2007-08-31 Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. Лекарственное средство для лечения диабета
US7381841B2 (en) 2003-08-22 2008-06-03 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylphenyl-substituted benzoylguanidines, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
DE102004054847A1 (de) * 2004-11-13 2006-05-24 Sanofi-Aventis Deutschland Gmbh Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4430916A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Alkyl-benzoylguanidin-Derivate
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
DE4437874A1 (de) * 1994-10-22 1996-04-25 Merck Patent Gmbh Alkyl-5-methylsulfonyl-benzoylguanidin-Derivate
DE19502644A1 (de) * 1995-01-28 1996-08-01 Merck Patent Gmbh 4-Amino-benzoylguanidin-Derivate
DE19502895A1 (de) * 1995-01-31 1996-08-01 Merck Patent Gmbh 4-Mercapto-benzoylguanidin-Derivate
DE19517848A1 (de) * 1995-05-16 1996-11-21 Merck Patent Gmbh Fluorhaltige Benzoylguanidine
DE19531138A1 (de) * 1995-08-24 1997-02-27 Merck Patent Gmbh Alkenyl-benzoylguanidin-Derivate

Also Published As

Publication number Publication date
CN1328452A (zh) 2001-12-26
BR9915667A (pt) 2001-08-14
HUP0104418A2 (hu) 2002-04-29
NO20012563L (no) 2001-05-25
ID29523A (id) 2001-09-06
JP2002530325A (ja) 2002-09-17
AR023064A1 (es) 2002-09-04
EP1131064A2 (en) 2001-09-12
PL348152A1 (en) 2002-05-06
KR20010080597A (ko) 2001-08-22
WO2000030624A3 (en) 2000-10-05
WO2000030624A2 (en) 2000-06-02
NO20012563D0 (no) 2001-05-25
CA2352154A1 (en) 2000-06-02
AU1553500A (en) 2000-06-13

Similar Documents

Publication Publication Date Title
EP0699666B1 (de) Heterocyclyl-benzoylguanidine
DE10161767A1 (de) 2-Guanidino-4-heterocyclyl-chinazoline
US6399658B1 (en) Composition containing ascorbic acid
EP1370525B1 (en) Biguanide derivatives
KR100406687B1 (ko) 알킬벤조일구아니딘유도체
CZ20011785A3 (cs) Pouľití benzoylguanidinů pro oąetřování diabetes mellitus nezávislého na inzulínu
CZ140896A3 (en) Derivative of fluorine containing benzoylguanidine, process of its preparation and pharmaceutical composition containing thereof
DE19706675A1 (de) Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP0723963B1 (de) 4-Amino-benzoylguanidin-Derivate
EP1441726A1 (de) Derivate des phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny!-valerian-säureamids und andere verbindungen als inhibitoren des koagulationsfaktors xa zur behandlung von thromboembolischen erkrankungen und tumoren
EP1385818A2 (de) Biurethanderivate
EP0725062B1 (de) 4-Mercapto-benzoylguanidin-Derivate
WO2003093235A1 (de) Carbonsäureamide als inhibitoren des koagulationsfaktors xa
CZ243598A3 (cs) Sulfonamidové deriváty, způsob jejich přípravy, farmaceutický přípravek, který je obsahuje, a jejich použití
MXPA01005295A (en) Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus
JPH0317083A (ja) 置換チエノピリミジン誘導体
DE19705133A1 (de) Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CN100398102C (zh) 含有草尿酸衍生物的肾衰竭用剂
DE10129508A1 (de) Verwendung von Inhibitoren des Na+/H+-Antiporters zur Krebsbekämpfung
WO1998037083A1 (de) Sulfonamid-substituierte thiophene, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament